An exploratory analysis of the ACCORD@/PRODIGE @ phase III trial was carried out to retrospectively compare the benefit of neoadjuvant chemotherapy between the elderly ( @ years ; n = @ ) and younger patients ( < @ years ; n = @ ) , this analysis was not preplanned in the study protocol .